Biologics Market Size, Share & Trends Report

Biologics Market Size, Share & Trends Analysis Report By Source (Microbial, Mammalian), By Products (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi), By Disease Category, By Manufacturing, And Segment Forecasts, 2020 - 2025

  • Report ID: GVR-1-68038-700-1
  • Number of Pages: 185
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2018
  • Industry: Healthcare

Table of Contents

Chapter 1 Research Methodology
                1.1 Information Procurement
                1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Biologics Market Variables, Trends & Scope
                3.1 Market Segmentation & Scope
                    3.1.1 Market Driver Analysis
                        3.1.1.1 Advancements in biomedical science
                        3.1.1.2 Rise in biologics contract manufacturing services
                        3.1.1.3 Several drugs going off patents
                        3.1.1.4 Commercial success of biologics
                    3.1.2 Market Restraint Analysis
                        3.1.2.1 Pharmacokinetics challenges associated with biologics
                        3.1.2.2 Rising control & cost for accessing biologics
                        3.1.2.3 Development of biosimilars
                3.2 Penetration & Growth Prospect Mapping for Product, 2016
                3.3 Biologics -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
                3.4 Industry Analysis - Porter’s
                3.5 Biologics: Pipeline Analysis
Chapter 4 Biologics Market: Source Estimates & Trend Analysis
                4.1 Global Biologics Market: Source Movement Analysis
                4.2 Microbial Source
                    4.2.1 Global microbial source market, 2014 - 2025 (USD Billion)
                4.3 Mammalian Source
                    4.3.1 Global mammalian source market, 2014 - 2025 (USD Billion)
                4.4 Others
                    4.4.1 Global other source market, 2014 - 2025 (USD Billion)
Chapter 5 Biologics Market: Product Estimates & Trend Analysis
                5.1 Global Biologics Market: Product Movement Analysis
                5.2 Monoclonal Antibodies
                    5.2.1 Global monoclonal antibodies market, 2014 - 2025 (USD Billion)
                    5.2.2 Monoclonal antibodies by application
                        5.2.2.1 Diagnostic monoclonal antibodies
                            5.2.2.1.1 Diagnostic MABs market, 2014 - 2025 (USD Billion)
                            5.2.2.1.2 Diagnostic MABs for biochemical analysis
                            5.2.2.1.3 Diagnostic MABs for imaging
                        5.2.2.2 Therapeutic MABs
                            5.2.2.2.1 Therapeutic MABs market, 2014 - 2025 (USD Billion)
                            5.2.2.2.2 Direct MABs
                            5.2.2.2.3 Targeting MABs
                        5.2.2.3 Protein purification MABs
                            5.2.2.3.1 Protein purification MABs market, 2014 - 2025 (USD Billion)
                        5.2.2.4 Other MABs
                            5.2.2.4.1 Other MABs market, 2014 - 2025 (USD Billion)
                    5.2.3 Monoclonal antibodies by type
                        5.2.3.1 Murine MABs
                            5.2.3.1.1 Murine MABs market, 2014 - 2025 (USD Billion)
                        5.2.3.2 Chimeric MABs
                            5.2.3.2.1 Chimeric MABs market, 2014 - 2025 (USD Billion)
                        5.2.3.3 Humanized MABs
                            5.2.3.3.1 Humanized MABs market, 2014 - 2025 (USD Billion)
                        5.2.3.4 Human MABs
                            5.2.3.4.1 Human MABs market, 2014 - 2025 (USD Billion)
                        5.2.3.5 Other MABs
                            5.2.3.5.1 Other MABs market, 2014 - 2025 (USD Billion)
                5.3 Vaccines
                    5.3.1 Global vaccines market, 2014 - 2025 (USD Billion)
                5.4 Recombinant Proteins
                    5.4.1 Global recombinant proteins market, 2014 - 2025 (USD Billion)
                5.5 Antisense, RNAi & Molecular Therapy
                    5.5.1 Global antisense, RNAi & molecular therapy market, 2014 - 2025 (USD Billion)
                5.6 Others
                    5.6.1 Global other product market, 2014 - 2025 (USD Billion)
Chapter 6 Biologics Market: Manufacturing Estimates & Trend Analysis
                6.1 Global Biologics Market: Manufacturing Movement Analysis
                6.2 Outsourced
                    6.2.1 Global outsourced market, 2014 - 2025 (USD Billion)
                6.3 In-house
                    6.3.1 Global in-house market, 2014 - 2025 (USD Billion)
Chapter 7 Biologics Market: Disease Category Estimates & Trend Analysis
                7.1 Global Biologics Market: Disease Category Movement Analysis
                7.2 Oncology
                    7.2.1 Global oncology market, 2014 - 2025 (USD Billion)
                    7.2.2 MABs market for oncology
                        7.2.2.1 Global MABs market for oncology, 2014 - 2025 (USD Billion)
                    7.2.3 Vaccines market for oncology
                        7.2.3.1 Global vaccines market for oncology, 2014 - 2025 (USD Billion)
                    7.2.4 Recombinant proteins market for oncology
                        7.2.4.1 Global recombinant proteins market for oncology, 2014 - 2025 (USD Billion)
                    7.2.5 Antisense, RNAi, & molecular therapy market for oncology
                        7.2.5.1 Global antisense, RNAi, & molecular therapy market for oncology, 2014 - 2025 (USD Billion)
                    7.2.6 Other products market for oncology
                        7.2.6.1 Global products market for oncology, 2014 - 2025 (USD Billion)
                7.3 Infectious Disease
                    7.3.1 Global infectious disease market, 2014 - 2025 (USD Billion)
                    7.3.2 Vaccines market for infectious disease
                        7.3.2.1 Global vaccines market for infectious disease, 2014 - 2025 (USD Billion)
                    7.3.3 MABs market for infectious disease
                        7.3.3.1 Global MABs market for infectious disease, 2014 - 2025 (USD Billion)
                    7.3.4 Antisense, RNAi, & molecular therapy market for infectious disease
                        7.3.4.1 Global antisense, RNAi, & molecular therapy market for infectious disease, 2014 - 2025 (USD Billion)
                    7.3.5 Recombinant proteins market for infectious disease
                        7.3.5.1 Global recombinant proteins market for infectious disease, 2014 - 2025 (USD Billion)
                    7.3.6 Other products market for infectious disease
                        7.3.6.1 Global products market for infectious disease, 2014 - 2025 (USD Billion)
                7.4 Immunological Disorders
                    7.4.1 Global immunological disorders market, 2014 - 2025 (USD Billion)
                7.5 Cardiovascular disorders
                    7.5.1 Global cardiovascular disorders market, 2014 - 2025 (USD Billion)
                7.6 Hematologic Disorders
                    7.6.1 Global hematologic disorders market, 2014 - 2025 (USD Billion)
                7.7 Others
                    7.7.1 Global other indications market, 2014 - 2025 (USD Billion)
Chapter 8 Biologics Market: Regional Estimates & Trend Analysis, by Source, Product, Manufacturing, & Disease Category
                8.1 Biologics Market Share By Region, 2015 & 2025
                8.2 North America
                    8.2.1 North America biologics market, 2014 - 2025 (USD Billion)
                    8.2.2 U.S.
                        8.2.2.1 U.S. biologics market, 2014 - 2025 (USD Billion)
                    8.2.3 Canada
                        8.2.3.1 Canada biologics market, 2014 - 2025 (USD Billion)
                8.3 Europe
                    8.3.1 Europe biologics market, 2014 - 2025 (USD Billion)
                    8.3.2 Germany
                        8.3.2.1 Germany biologics market, 2014 - 2025 (USD Billion)
                    8.3.3 UK
                        8.3.3.1 UK biologics market, 2014 - 2025 (USD Billion)
                8.4 Asia Pacific
                    8.4.1 Asia Pacific biologics market, 2014 - 2025 (USD Billion)
                    8.4.2 Japan
                        8.4.2.1 Japan biologics market, 2014 - 2025 (USD Billion)
                    8.4.3 China
                        8.4.3.1 China biologics market, 2014 - 2025 (USD Billion)
                8.5 Latin America
                    8.5.1 Latin America biologics market, 2014 - 2025 (USD Billion)
                    8.5.2 Brazil
                        8.5.2.1 Brazil biologics market, 2014 - 2025 (USD Billion)
                8.6 Middle East & Africa (MEA)
                    8.6.1 Middle East & Africa biologics market, 2014 - 2025 (USD Billion)
                    8.6.2 South Africa
                        8.6.2.1 South Africa biologics market, 2014 - 2025 (USD Billion)
Chapter 9 Competitive Landscape
                9.1 Strategy Framework
                9.2 Market Participation Categorization
                9.3 Company Profiles
                    9.3.1 Samsung BioLogics
                        9.3.1.1 Company overview
                        9.3.1.2 Financial performance
                        9.3.1.3 Product benchmarking
                        9.3.1.4 Strategic initiatives
                    9.3.2 Amgen
                        9.3.2.1 Company overview
                        9.3.2.2 Financial performance
                        9.3.2.3 Product benchmarking
                        9.3.2.4 Strategic initiatives
                    9.3.3 Novo Nordisk A/S
                        9.3.3.1 Company overview
                        9.3.3.2 Financial performance
                        9.3.3.3 Product benchmarking
                        9.3.3.4 Strategic initiatives
                    9.3.4 AbbVie Inc.
                        9.3.4.1 Company overview
                        9.3.4.2 Financial performance
                        9.3.4.3 Product benchmarking
                        9.3.4.4 Strategic initiatives
                    9.3.5 Sanofi
                        9.3.5.1 Company overview
                        9.3.5.2 Financial performance
                        9.3.5.3 Product benchmarking
                        9.3.5.4 Strategic initiatives
                    9.3.6 Johnson & Johnson Services, Inc
                        9.3.6.1 Company overview
                        9.3.6.2 Financial performance
                        9.3.6.3 Product benchmarking
                        9.3.6.4 Strategic initiatives
                    9.3.7 Pfizer Inc.
                        9.3.7.1 Company overview
                        9.3.7.2 Financial performance
                        9.3.7.3 Product benchmarking
                        9.3.7.4 Strategic initiatives
                    9.3.8 Merck & Co., Inc.
                        9.3.8.1 Company overview
                        9.3.8.2 Financial performance
                        9.3.8.3 Product benchmarking
                    9.3.9 GSK group of companies
                        9.3.9.1 Company overview
                        9.3.9.2 Financial performance
                        9.3.9.3 Product benchmarking
                        9.3.9.4 Strategic initiatives
                    9.3.10 Celltrion
                        9.3.10.1 Company overview
                        9.3.10.2 Financial performance
                        9.3.10.3 Product benchmarking
                        9.3.10.4 Strategic initiatives
                    9.3.11 Precision Biologics, Inc.
                        9.3.11.1 Company overview
                        9.3.11.2 Financial performance
                        9.3.11.3 Product benchmarking
                        9.3.11.4 Strategic initiatives
                    9.3.12 Merck KGaA
                        9.3.12.1 Company overview
                        9.3.12.2 Financial performance
                        9.3.12.3 Product benchmarking
                        9.3.12.4 Strategic initiatives
                    9.3.13 Eli Lilly and Company
                        9.3.13.1 Company overview
                        9.3.13.2 Financial performance
                        9.3.13.3 Product benchmarking
                    9.3.14 Novartis AG
                        9.3.14.1 Company overview
                        9.3.14.2 Financial performance
                        9.3.14.3 Product benchmarking
                        9.3.14.4 Strategic initiatives
                    9.3.15 Bayer AG
                        9.3.15.1 Company overview
                        9.3.15.2 Financial performance
                        9.3.15.3 Product benchmarking
                        9.3.15.4 Strategic initiatives
                    9.3.16 F. Hoffmann-La Roche Ltd
                        9.3.16.1 Company overview
                        9.3.16.2 Financial performance
                        9.3.16.3 Product benchmarking
                        9.3.16.4 Strategic initiatives
                    9.3.17 AstraZeneca
                        9.3.17.1 Company overview
                        9.3.17.2 Financial performance
                        9.3.17.3 Product benchmarking
                        9.3.17.4 Strategic initiatives


List of Tables

TABLE 1 North America biologics market estimates& forecasts, by source, 2014 - 2025 (USD Billion)
TABLE 2 North America biologics market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 3 North America monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 4 North America diagnostic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 5 North America therapeutic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 6 North America monoclonal antibodies market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 7 North America biologics market estimates & forecasts, by manufacturing, 2014 - 2025 (USD Billion)
TABLE 8 North America biologics market estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Billion)
TABLE 9 North America oncology biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 10 North America infectious diseases biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 11 U.S. biologics market estimates& forecasts, by source, 2014 - 2025 (USD Billion)
TABLE 12 U.S. biologics market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 13 U.S. monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 14 U.S. diagnostic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 15 U.S. therapeutic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 16 U.S. monoclonal antibodies market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 17 U.S. biologics market estimates & forecasts, by manufacturing, 2014 - 2025 (USD Billion)
TABLE 18 U.S. biologics market estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Billion)
TABLE 19 U.S. oncology biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 20 U.S. infectious diseases biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 21 Canada biologics market estimates& forecasts, by source, 2014 - 2025 (USD Billion)
TABLE 22 Canada biologics market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 23 Canada monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 24 Canada diagnostic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 25 Canada therapeutic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 26 Canada monoclonal antibodies market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 27 Canada biologics market estimates & forecasts, by manufacturing, 2014 - 2025 (USD Billion)
TABLE 28 Canada biologics market estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Billion)
TABLE 29 Canada oncology biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 30 Canada infectious diseases biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 31 Europe biologics market estimates& forecasts, by source, 2014 - 2025 (USD Billion)
TABLE 32 Europe biologics market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 33 Europe monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 34 Europe diagnostic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 35 Europe therapeutic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 36 Europe monoclonal antibodies market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 37 Europe biologics market estimates & forecasts, by manufacturing, 2014 - 2025 (USD Billion)
TABLE 38 Europe biologics market estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Billion)
TABLE 39 Europe oncology biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 40 Europe infectious diseases biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 41 Germany biologics market estimates& forecasts, by source, 2014 - 2025 (USD Billion)
TABLE 42 Germany biologics market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 43 Germany monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 44 Germany diagnostic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 45 Germany therapeutic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 46 Germany monoclonal antibodies market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 47 Germany biologics market estimates & forecasts, by manufacturing, 2014 - 2025 (USD Billion)
TABLE 48 Germany biologics market estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Billion)
TABLE 49 Germany oncology biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 50 Germany infectious diseases biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 51 UK biologics market estimates& forecasts, by source, 2014 - 2025 (USD Billion)
TABLE 52 UK biologics market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 53 UK monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 54 UK diagnostic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 55 UK therapeutic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 56 UK monoclonal antibodies market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 57 UK biologics market estimates & forecasts, by manufacturing, 2014 - 2025 (USD Billion)
TABLE 58 UK biologics market estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Billion)
TABLE 59 UK oncology biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 60 UK infectious diseases biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 61 Asia Pacific biologics market estimates& forecasts, by source, 2014 - 2025 (USD Billion)
TABLE 62 Asia Pacific biologics market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 63 Asia Pacific monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 64 Asia Pacific diagnostic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 65 Asia Pacific therapeutic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 66 Asia Pacific monoclonal antibodies market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 67 Asia Pacific biologics market estimates & forecasts, by manufacturing, 2014 - 2025 (USD Billion)
TABLE 68 Asia Pacific biologics market estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Billion)
TABLE 69 Asia Pacific oncology biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 70 Asia Pacific infectious diseases biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 71 Japan biologics market estimates& forecasts, by source, 2014 - 2025 (USD Billion)
TABLE 72 Japan biologics market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 73 Japan monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 74 Japan diagnostic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 75 Japan therapeutic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 76 Japan monoclonal antibodies market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 77 Japan biologics market estimates & forecasts, by manufacturing, 2014 - 2025 (USD Billion)
TABLE 78 Japan biologics market estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Billion)
TABLE 79 Japan oncology biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 80 Japan infectious diseases biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 81 China biologics market estimates& forecasts, by source, 2014 - 2025 (USD Billion)
TABLE 82 China biologics market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 83 China monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 84 China diagnostic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 85 China therapeutic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 86 China monoclonal antibodies market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 87 China biologics market estimates & forecasts, by manufacturing, 2014 - 2025 (USD Billion)
TABLE 88 China biologics market estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Billion)
TABLE 89 China oncology biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 90 China infectious diseases biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 91 Latin America biologics market estimates & forecasts, by source, 2014 - 2025 (USD Billion)
TABLE 92 Latin America biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 93 Latin America monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 94 Latin America diagnostic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 95 Latin America therapeutic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 96 Latin America monoclonal antibodies market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 97 Latin America biologics market estimates & forecasts, by manufacturing, 2014 - 2025 (USD Billion)
TABLE 98 Latin America biologics market estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Billion)
TABLE 99 Latin America oncology biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 100 Latin America infectious diseases biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 101 Brazil biologics market estimates& forecasts, by source, 2014 - 2025 (USD Billion)
TABLE 102 Brazil biologics market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 103 Brazil monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 104 Brazil diagnostic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 105 Brazil therapeutic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 106 Brazil monoclonal antibodies market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 107 Brazil biologics market estimates & forecasts, by manufacturing, 2014 - 2025 (USD Billion)
TABLE 108 Brazil biologics market estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Billion)
TABLE 109 Brazil oncology biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 110 Brazil infectious diseases biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 111 MEA biologics market estimates& forecasts, by source, 2014 - 2025 (USD Billion)
TABLE 112 MEA biologics market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 113 MEA monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 114 MEA diagnostic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 115 MEA therapeutic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 116 MEA monoclonal antibodies market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 117 MEA biologics market estimates & forecasts, by manufacturing, 2014 - 2025 (USD Billion)
TABLE 118 MEA biologics market estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Billion)
TABLE 119 MEA oncology biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 120 MEA infectious diseases biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 121 South Africa biologics market estimates& forecasts, by source, 2014 - 2025 (USD Billion)
TABLE 122 South Africa biologics market estimates& forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 123 South Africa monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 124 South Africa diagnostic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 125 South Africa therapeutic monoclonal antibodies market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 126 South Africa monoclonal antibodies market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 127 South Africa biologics market estimates & forecasts, by manufacturing, 2014 - 2025 (USD Billion)
TABLE 128 South Africa biologics market estimates & forecasts, by therapeutic area, 2014 - 2025 (USD Billion)
TABLE 129 South Africa oncology biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
TABLE 130 South Africa infectious diseases biologics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)


List of Figures

FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping for Product, 2016
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Global biologics market: Source outlook key takeaways
FIG. 16 Global biologics market: Source movement analysis
FIG. 17 Global microbial source market, 2014 - 2025 (USD Billion)
FIG. 18 Global mammalian source market, 2014 - 2025 (USD Billion)
FIG. 19 Global other source market, 2014 - 2025 (USD Billion)
FIG. 20 Global biologics market: Product outlook key takeaways
FIG. 21 Global biologics market: Product movement analysis
FIG. 22 Global monoclonal antibodies market, 2014 - 2025 (USD Billion)
FIG. 23 Global diagnostic MABs market, 2014 - 2025 (USD Billion)
FIG. 24 Global diagnostic MABs for biochemical analysis market, 2014 - 2025 (USD Billion)
FIG. 25 Global diagnostic MABs for imaging market, 2014 - 2025 (USD Billion)
FIG. 26 Global therapeutic MABs market, 2014 - 2025 (USD Billion)
FIG. 27 Global direct MABs market, 2014 - 2025 (USD Billion)
FIG. 28 Global targeting MABs market, 2014 - 2025 (USD Billion)
FIG. 29 Global protein purification MABs market, 2014 - 2025 (USD Billion)
FIG. 30 Other MABs market, 2014 - 2025 (USD Billion)
FIG. 31 Global murine MABs market, 2014 - 2025 (USD Billion)
FIG. 32 Global chimeric MABs market, 2014 - 2025 (USD Billion)
FIG. 33 Global humanized MABs market, 2014 - 2025 (USD Billion)
FIG. 34 Global human MABs market, 2014 - 2025 (USD Billion)
FIG. 35 Global other MABs market, 2014 - 2025 (USD Billion)
FIG. 36 Global vaccines market, 2014 - 2025 (USD Billion)
FIG. 37 Global recombinant proteins market, 2014 - 2025 (USD Billion)
FIG. 38 Global antisense, RNAi & molecular therapy market, 2014 - 2025 (USD Billion)
FIG. 39 Global other product market, 2014 - 2025 (USD Billion)
FIG. 40 Global biologics market: Manufacturing outlook key takeaways
FIG. 41 Global biologics market: Manufacturing movement analysis
FIG. 42 Global outsourced market, 2014 - 2025 (USD Billion)
FIG. 43 Global in-house market, 2014 - 2025 (USD Billion)
FIG. 44 Global biologics market: Disease category outlook key takeaways
FIG. 45 Global biologics market: Disease category movement analysis
FIG. 46 Global oncology market, 2014 - 2025 (USD Billion)
FIG. 47 Global infectious disease market, 2014 - 2025 (USD Billion)
FIG. 48 Global immunological disorders market, 2014 - 2025 (USD Billion)
FIG. 49 Global cardiovascular disorders market, 2014 - 2025 (USD Billion)
FIG. 50 Global hematologic disorders market, 2014 - 2025 (USD Billion)
FIG. 51 Global other indications market, 2014 - 2025 (USD Billion)
FIG. 52 Regional market place: Key takeaway
FIG. 53 Biologics regional outlook, 2016 & 2025
FIG. 54 North America biologics market, 2014 - 2025 (USD Billion)
FIG. 55 U.S. biologics market, 2014 - 2025 (USD Billion)
FIG. 56 Canada biologics market, 2014 - 2025 (USD Billion)
FIG. 57 Europe biologics market, 2014 - 2025 (USD Billion)
FIG. 58 Germany biologics market, 2014 - 2025 (USD Billion)
FIG. 59 UK biologics market, 2014 - 2025 (USD Billion)
FIG. 60 Asia Pacific biologics market, 2014 - 2025 (USD Billion)
FIG. 61 Japan biologics market, 2014 - 2025 (USD Billion)
FIG. 62 China biologics market, 2014 - 2025 (USD Billion)
FIG. 63 Latin America biologics market, 2014 - 2025 (USD Billion)
FIG. 64 Brazil biologics market, 2014 - 2025 (USD Billion)
FIG. 65 Middle East & Africa biologics market, 2014 - 2025 (USD Billion)
FIG. 66 South Africa biologics market, 2014 - 2025 (USD Billion)
FIG. 67 Strategy framework
FIG. 68 Participant categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.